A.L. Jackman
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Rheumatology top 10%
- Folate and B Vitamins Research
Papers in
-
- Biochemical and Molecular Research 11
- Cancer therapeutics and mechanisms 3
- Oncology 15
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 4
- Co-authors
- A H Calvert (8 shared papers)Rosemary Kimbell (3 shared papers)Melody Brown (2 shared papers)William Gibson (1 shared paper)G. Wynne Aherne (6 shared papers)Anthea Hardcastle (2 shared papers)Lloyd R. Kèlland (2 shared papers)Jenny Titley (2 shared papers)
- Journals
- British Journal of Cancer (4 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)Cytometry (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United KingdomUnited StatesIsrael
In The Last Decade
A.L. Jackman
23 papers receiving 813 citations
Peers
Comparison fields: 5 of 59
- Oncology 513
- Rheumatology 140
- Molecular Biology 503
- Cancer Research 74
- Hematology 52
Countries citing papers authored by A.L. Jackman
This map shows the geographic impact of A.L. Jackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Jackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Jackman more than expected).
Fields of papers citing papers by A.L. Jackman
This network shows the impact of papers produced by A.L. Jackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Jackman. The network helps show where A.L. Jackman may publish in the future.
Co-authors
The 25 scholars most cited alongside A.L. Jackman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. | 1991 | 322 |
| 2 | 1995 | 88 | |
| 3 | 1986 | 87 | |
| 4 | Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. | 2000 | 66 |
| 5 | Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo. | 1990 | 52 |
| 6 | 1995 | 33 | |
| 7 | 1995 | 27 | |
| 8 | 1998 | 26 | |
| 9 | 1987 | 26 | |
| 10 | Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717). | 1987 | 25 |
| 11 | Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicity. | 2000 | 20 |
| 12 | Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies. | 2000 | 18 |
| 13 | 1998 | 17 | |
| 14 | 1999 | 10 | |
| 15 | 1994 | 7 | |
| 16 | 1998 | 5 | |
| 17 | Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) | 1987 | 5 |
| 18 | 1986 | 3 | |
| 19 | 2-AMINO-4-HYDROXY QUINAZOLINE ANALOGS OF FOLIC-ACID AS THYMIDYLATE SYNTHETASE INHIBITORS | 1979 | 1 |
| 20 | BIOCHEMICAL DISTURBANCES OBSERVED INVITRO AND INVIVO FOLLOWING INHIBITION OF THYMIDYLATE SYNTHETASE BY C-3717 | 1982 | 1 |
About A.L. Jackman
A.L. Jackman is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Genetics, having authored 24 papers that have together received 842 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Biochemical and Molecular Research (11 papers), Quinazolinone synthesis and applications (6 papers), Cancer Treatment and Pharmacology (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (513 citations), Rheumatology (140 citations), Molecular Biology (503 citations), Cancer Research (74 citations) and Hematology (52 citations). A.L. Jackman has collaborated with scholars based in United Kingdom, United States and Israel. Frequent co-authors include A H Calvert, Rosemary Kimbell, Melody Brown, William Gibson, G. Wynne Aherne, Anthea Hardcastle, Lloyd R. Kèlland, Jenny Titley, Lisa Brunton and S. J. Harland. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Journal of Clinical Oncology, Cytometry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.